ArticleFrontiers in oncology2025

Pressure enabled drug delivery (PEDD) of nelitolimod increased therapeutic delivery, reduced immunosuppression, and improved efficacy in porcine and murine liver tumor models.

Lauren Cournoyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.